Evidence map›Paper›PMID 41910724›Full record

ReviewBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2026

[Requirements for the rational use of antibiotics based on antibiotic stewardship].

Katja de With, Rika Draenert, Dennis Nurjadi, Stefan Hagel, Ulrike Trost, Jan Fahrenkrog-Petersen, Winfried V Kern, Evelyn Kramme

Abstract readEnglish AbstractReview
In one paragraph

Review in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Katja de WithKlinische Infektiologie, Institut für Infektiologie und Krankenhaushygiene, Universitätsklinikum Carl Gustav Carus an der TU Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland. katja.dewith@ukdd.de.
Rika DraenertStabsstelle ABS, LMU Klinikum, München, Deutschland.
Dennis NurjadiInstitut für Medizinische Mikrobiologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Deutschland.
Stefan HagelInstitut f. Infektionsmedizin u. Krankenhaushygiene, Universitätsklinikum Jena, Jena, Deutschland.
Ulrike TrostApotheke und Fächerverbund für Infektiologie, Pneumologie und Intensivmedizin, Charité - Universitätsmedizin, Campus Virchow-Klinikum, Berlin, Deutschland.
Jan Fahrenkrog-PetersenApotheke, Pharmazeutische Logistik, Ambulanzversorgung, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Deutschland.
Winfried V KernAkademie für Infektionsmedizin e. V., Berlin, Deutschland.
Evelyn KrammeSektion Antimicrobial Stewardship (AMS), Deutsche Gesellschaft für Infektiologie e. V., Berlin, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given the inadequate and excessive use of antibiotics and the critical development of resistance, the rational prescription of antibiotics has become a key priority in human medicine. A broad range of initiatives to optimize antibiotic use has already been implemented in Germany. These include comprehensive antibiotic stewardship (ABS) training leading to the certification of ABS specialists; the development of a guideline for ABS programs in hospitals; the establishment of regional ABS networks integrating expertise from clinical practice, pharmacy, and microbiology; and the execution of funded interventional studies within the outpatient sector. There is significant potential for improvement in the establishment and financing of ABS teams, infectious disease consultation services, and infection boards in hospitals as well as in the promotion of innovative microbiological diagnostics and the development of sustainable concepts for outpatient care. The systematic integration of microbiological and pharmaceutical expertise into ABS programs is essential, as is the ongoing implementation and further development of modern electronic prescription systems. All these measures substantially improve prescription quality and support key strategies for targeted therapy and shorter treatment durations. To ensure the long-term establishment of these new structures and their further development at intersectoral interfaces, political support and substantial investment are indispensable.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipBacterial InfectionsGermanyHumansPractice Guidelines as TopicAnti-Bacterial AgentsABS teamAntibiotic prescribingAntimicrobial resistanceAntimicrobial stewardshipDiagnostic stewardship

Identifiers

PMID41910724
PMCPMC13133214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.